e-learning
resources
ERJ
Supplements
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Analysis of fluid{-}phase mediators
Kelly M.M., Keatings V., Leigh R., Peterson C., Shute J., Venge P., Djukanovic R.
Source:
Eur Respir J 2002; 20: 24S-39S
Journal Issue:
July 2002 - Suppl. 37
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Kelly M.M., Keatings V., Leigh R., Peterson C., Shute J., Venge P., Djukanovic R.. Analysis of fluid{-}phase mediators. Eur Respir J 2002; 20: 24S-39S
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Proinflammatory cytokine production during exercise: role of antioxidants and monocytes
Source: Eur Respir J 2002; 20: Suppl. 38, 288s
Year: 2002
Proteome profiling reveals candidate mediators of TGF-β-induced glucocorticoid resistance
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015
Analysis of oxymetazolines´ inflammation inhibiting and resolving properties in human neutrophils
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009
Induced sputum cytokines and chemokines and mechanistic pathways in adult asthma phenotypes
Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes
Year: 2013
Airway fibroblasts phenotype markers after pro-inflammatory cytokines challenge
Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma
Year: 2009
Role of anti-inflammatory treatments in complex chronic comorbidities
Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases
Year: 2006
Study of influence of interleukin-1b on cytokines production in inflammatory sites
Source: Annual Congress 2007 - Improving asthma therapy - new findings in established and experimental treatment modalities
Year: 2007
Regulation of inflammation
Source: Lung Science Conference 2004 - Application of our knowledge of the basic processes of lung inflammation in lung diseases
Year: 2004
Aerobic training inhibits leukocytes production of oxidants, pro-inflammatory and pro-fibrotic factors reducing asthmatic phenotype
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012
Proinflammatory cytokines in induced sputum and COPD phenotype
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
Activation of HIF-1 by mediators of inflammation
Source: Lung Science Conference 2007 - Translational research in pulmonary disease: Hypoxia-driven mechanisms
Year: 2007
Mouse pathway biology models: Investigating the biology of alternaria alternata induced lung inflammation in the mouse - Role of ILC2 and Th2 cytokines
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
Proteomic profiling to define synergistic responses mediated by IL-17 and TNFa in the lungs
Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Year: 2018
Analysis of P2Y
12
receptor responsiveness to cysteinyl leukotrienes
Source: Annual Congress 2011 - Asthma: basic science and clinical studies
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept